Product Information
AMOXICILLIN 250 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0687 per EA under NDC 57237003005. Its NADAC has been published 652 times since Apr 9, 2014.
FDA first approved this application on Nov 9, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237003005
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLINApproval Type
Generic (ANDA)
FDA Application
ANDA065271FDA Approved
11/9/2005
TE Code
AB
On Market Since
11/9/2005
Pharmacological Classes
Price Statistics
The NADAC for AMOXICILLIN 250 MG CAPSULE has been published 652 times since Apr 9, 2014, and over the history we have for it it has declined 21.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0687 per EA |
|---|---|
| All-time high | $0.0893 (Sep 11, 2019) |
| All-time low | $0.0520 (Mar 22, 2023) |
| 52-week high | $0.0687 |
| 52-week low | $0.0586 |
| Median price | $0.0718 |
| Average price | $0.0715 |
| Largest weekly change | +33.1% (Aug 19, 2020) |
| Weeks tracked | 652 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOXICILLIN 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for AMOXICILLIN 250 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0687 per EA (NDC 57237003005), effective Sep 30, 2026.
How has the price of AMOXICILLIN 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for AMOXICILLIN 250 MG CAPSULE has declined 21.6%. It has been tracked across 652 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for AMOXICILLIN 250 MG CAPSULE?
Since Apr 9, 2014, the NADAC for AMOXICILLIN 250 MG CAPSULE has ranged from a low of $0.0520 (Mar 22, 2023) to a high of $0.0893 (Sep 11, 2019), with a median of $0.0718 per EA.
Are there cheaper alternatives to AMOXICILLIN 250 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOXICILLIN 250 MG CAPSULE, is $0.0684 per EA — about 1% below AMOXICILLIN 250 MG CAPSULE.
Who manufactures AMOXICILLIN 250 MG CAPSULE?
AMOXICILLIN 250 MG CAPSULE (NDC 57237003005) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.